The global protein market is experiencing a significant boom, largely fueled by the surging use of GLP-1 weight-loss drugs and a growing consumer focus on healthier eating. This increased demand has led to a near doubling in the price of key protein ingredients like whey protein concentrate (WPC 80), which has risen by almost 90% in the last year to $23,410 per metric ton. This price surge far outpaces other dairy segments, including powdered milk and cheese, and is considered a "gravity-defying" rally by analysts.
Food producers and dairy companies are struggling to keep up with this escalating demand. Inventories of whey protein have fallen approximately 50% since 2023, and some suppliers are sold out for the remainder of the year. The food industry currently lacks the necessary infrastructure to process whey into the high-protein concentrates and isolates required by the market, creating a significant capacity shortage. This situation is making it difficult for buyers to secure supply, with prices for whey protein isolate reaching as high as $14 per pound, up from $7 per pound in late 2024.
In response to the protein surge, major dairy companies such as Arla Foods and FrieslandCampina are investing heavily in expanding whey production capacity. FrieslandCampina, for instance, has invested more than $90 million to accelerate its growth in high-value whey proteins, including acquiring Wisconsin Whey Protein and doubling capacity at its Dutch Borculo plant. Food manufacturers like Danone and Bel Group are also broadening their protein-rich product offerings, with examples including Danone's Oikos yogurt and Bel Group's Babybel Protein. The largest U.S. dairy farm cooperative, DFA, launched MULU, a cottage cheese with added whey providing 18 grams of protein per half-cup serving, compared to the typical 12-13 grams.
The demand for protein is further amplified by a broader trend among consumers to incorporate more protein into their diets, with around 70% of Americans now aiming to consume more protein, up from 59% four years ago. This trend, coupled with the requirements of GLP-1 drug users to increase protein intake to mitigate muscle loss, is placing immense pressure on the supply chain. Expanding infrastructure to meet this demand is a costly and time-consuming endeavor, with single plant revamps estimated at $15 million and large-scale industrial expansion requiring hundreds of millions of dollars. The U.S. dairy industry, however, has announced $11 billion in new manufacturing capacity across 19 states to grow milk production significantly in the next five years.
